LIAN Group Unveils Vitaura to Transform Aesthetic Medicine

Deal News | Nov 28, 2024 | Finance Community IT - 1 Corporate M&A

LIAN Group Unveils Vitaura to Transform Aesthetic Medicine

LIAN Group, a specialist in private equity and venture building, has launched Vitaura, a consolidation initiative in the aesthetic medicine, surgery, and longevity sector in Italy. Vitaura aims to create a network of excellence offering integrated support to clinics and professionals by providing high-quality standards and resource optimization across various facilities. The team involved includes key figures at LIAN Group and legal advisors from prominent firms, with financing from Banca Profilo. The COO for Vitaura is Andrea Grassi, esteemed for his leadership in similar businesses. The global aesthetic medicine and surgery market is set to grow significantly, with Italy's market seeing substantial expansion. Vitaura plans to acquire and integrate recognized entities into a centralized management model that allows medical professionals to focus on clinical activities while leveraging synergies. The initiative begins with the acquisition of Medicina Estetica Zazzaron. Further acquisitions are planned, aiming for expansion and maintaining clinic autonomy.

Sectors

  • Healthcare
  • Private Equity

Geography

  • Italy – The activities described, including the launch of Vitaura and future clinic acquisitions, are primarily located in Italy, making it the relevant geographic focus.

Industry

  • Healthcare – The article revolves around the healthcare sector, specifically focusing on aesthetic medicine, surgery, and longevity services while highlighting the consolidation of these services.
  • Private Equity – LIAN Group, a private equity firm, is spearheading the initiative, indicating active involvement from the private equity industry in the healthcare sector.

Financials

  • 15.4 billion USD – Value of the global market for aesthetic medicine and surgery in 2023.
  • 300 million USD – Estimated value of the Italian market for aesthetic medicine in 2023.
  • 11% – Annual growth rate forecast for the global aesthetic medicine market.

Participants

NameRoleTypeDescription
LIAN GroupInvestment FirmCompanyThe driving force behind the Vitaura initiative, specializing in private equity and venture building.
VitauraConsolidation InitiativeCompanyVitaura is a new initiative by LIAN Group aiming to consolidate aesthetic medicine services in Italy.
Medicina Estetica ZazzaronTarget CompanyCompanyThe initial acquisition by Vitaura, a renowned clinic in the aesthetic medicine sector in Italy.
Fiorenzo ManganielloManaging Partner & Co-FounderPersonPart of the LIAN Group team working on the Vitaura initiative.
Andrea GrassiCOO and Business Development HeadPersonOverseeing the operational growth and business development for Vitaura.
Gianni & OrigoniLegal AdvisorCompanyProvided legal advisory services for the Vitaura project.
Giovannelli e AssociatiLegal AdvisorCompanyLegal advisor assisting LIAN Group in the Vitaura initiative.
TaxNetLegal and Tax AdvisorCompanyAssisted LIAN Group with legal and tax services for the Vitaura project.
Studio Pea CommercialistiM&A AdvisorCompanyAdvised Medicina Estetica Zazzaron for the acquisition process.
Banca ProfiloFinancierCompanyProvided financial backing for the acquisition part of the Vitaura initiative.